Share

Anticancer Agent Also Suppresses Insulin Secretion in Metastatic Insulinoma

The immunosuppressant and anticancer agent everolimus has been shown to directly suppress insulin secretion in metastatic insulinoma, independently of the drug’s effect on tumor growth, according to a study recently published in the Journal of the Endocrine Society. Researchers led by Takeshi Miyatsuka, MD, PhD, of the Department of Metabolism and Endocrinology, Juntendo University Graduate...
Share

Getting the ACT Together: Tumor Database Improves Pediatric Care

stjude_fiftyfacts_625px The International Pediatric Adrenocortical Tumor Registry is a database for young patients afflicted with these rare tumors. The result has created more personalized and targeted care as well as benefited the patient’s families and their physicians. Last October, the Journal of Clinical Oncology published a paper that described the clinical features and outcomes in children with...
Share

CLARIFICATION: BCG Vaccine May Lead to Long-Term Improvement in Blood Sugar Levels in Patients with Type 1 Diabetes, Study Shows

[CLARIFICATION: The results of this study were based on a small sample of patients who continued insulin treatment, and further research is needed. A previous version of this article seemed to imply that the BCG vaccine alone restored normal blood sugar levels. That is not the case; we regret the error.] Long-term follow-up of participants...
Share

Positive Top-Line Results Announced from the Pivotal Phase 3 SONICS Study of Levoketoconazole for the Treatment of Endogenous Cushing’s Syndrome

Positive top-line results this week were announced from the multinational, pivotal Phase 3 SONICS study evaluating levoketoconazole for the treatment of endogenous Cushing’s syndrome. Strongbridge Biopharma is marketing the drug as RECORLEV™ . The open-label, single-arm SONICS study achieved statistical significance of its pre-specified primary endpoint, with 30 percent of patients achieving normalization of mean urinary...
Share

Listen to Episode 4 of the Endocrine News Podcast

Episode 4 of the Endocrine News Podcast has arrived, in which Angela Magdaleno, DO, of the Lehigh Valley Health Network, discusses preconception counseling for women with diabetes. Listen here: https://www.endocrine.org/podcast#enp4 And check out the links below for further reading: https://www.endocrine.org/meetings/endo-annual-meetings/abstract-details?id=6796 — ENDO 2018 abstract: Preconception Counseling: Frequently Forgotten by Primary Care Providers due to Multiple Barriers...

As much as we know today about the endocrine system and the effects it has on the body, there remains so much that we do not know. Discoveries are made every day, and our understanding of the endocrine system is always growing and changing. Serving patients to the best of an endocrinologist’s abilities means being aware of all the latest developments in endocrine research. This includes the newest and most complete information concerning such endocrinology research topics as new treatments and new methods for disease prevention. Identifying symptoms and making the connections between those symptoms and endocrine disease can lead to greater understanding and ultimately better treatment for patients. More advanced prevention techniques can help patients stave off disease before it can impact their lives. Having the most current information can make a tremendous difference in the quality of life for your patients.

This section features some of the most current and forward-looking articles concerning the latest research in endocrinology. Written by and for endocrinologists, these articles are provided to keep you up to date with the most relevant developments in the field of endocrinology. You can access the information you need about new technology, new treatments and general information to help you serve your patients with better overall care. Our understanding of the endocrine system is always evolving. With Endocrine News, you can ensure that your knowledge of the field won’t be left behind. What’s more, your patients will always have access to the most advanced information out there.